A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Key facts

Sponsor

Creative Biosciences (Guangzhou) Co., Ltd.

Principal Investigator

Lei Zheng, PhD

Nanfang Hospital of Southern Medccal University

Intervention

Diagnostic Test: Sputum DNA methylation analysis(diagnostic_test)

Enrollment

1564 enrolled

Eligibility

All sexes

Timeline

2022 – 2025

Study locations (1)

• Nanfang Hospital of Southern Medccal University, Guangzhou, Guangdong, China

Collaborators

Guangzhou Xiangkang Medical Research Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute interstitial pneumonia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNANCT06526884
  Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
  University of California, Los Angeles
• RECRUITINGNCT05681962
  Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
  University Magna Graecia

See all trials for Acute interstitial pneumonia →